期刊文献+
共找到1,577篇文章
< 1 2 79 >
每页显示 20 50 100
Effects of different concentrations of dexamethasone on pulmonary histology in rats with chronic asthma
1
作者 Feng-Chun Ren Qing-Wen Xu +2 位作者 Lei-Ling Han Yan Wu Hui-Zhi Zhu 《Journal of Hainan Medical University》 2020年第2期1-6,共6页
Objective:To observe the intervention effects of different concentrations of dexamethasone on the general situation and pulmonary histology of chronic asthma rats,and to explore the suitable intragastric dose of dexam... Objective:To observe the intervention effects of different concentrations of dexamethasone on the general situation and pulmonary histology of chronic asthma rats,and to explore the suitable intragastric dose of dexamethasone in the rat model of chronic asthma.Methods:75 healthy male Sprague-Dawley(SD)rats were randomly divided into normal group,M group,dexamethasone low dose,middle dose and high dose group by random number table.The rat model of chronic asthma was established by sensitization and challenge of ovalbumin(OVA).From the 20th day of the experiment,dexamethasone groups were given intragastric administration of 0.0625mg/(kg·d),0.125mg/(kg·d)and 0.5mg/(kg·d),respectively.The general situation of rats was observed and recorded.The histological changes of rat lungs were observed by HE staining and Masson staining.Results:The degree of inflammatory infiltration of bronchus and surrounding tissue in the M group was significantly higher than that in the normal group(P<0.01).The thickness of airway wall and smooth muscle and the deposition of airway collagen in the M group were significantly higher than those in the normal group(P<0.01).After one week of intervention,the average daily food intake and body mass of rats in the high dose group were significantly lower than those in the M group(P<0.01),and the increase in body mass in the middle and low dose groups was significantly slower than that in the M group(P<0.01).After 2 weeks of intervention,the average daily food intake of rats in the middle and low dose groups was significantly lower than that in the M group(P<0.01).After 4 weeks of intervention,the average daily food intake in the middle and low dose groups was significantly lower than that in the low dose group(P<0.01).The inflammatory infiltration of lung tissue in the middle and low dose groups was significantly less than that in the model group,and the thickness of airway wall and smooth muscle and the deposition of airway collagen in the middle and low dose groups were significantly lower than those in the model group(P<0.01).There was no difference between the two groups(P>0.05).A large number of rats in the high dose group died after 5 times of intervention.Three rats died in the DEXM group at the 5th week of intervention,and there was no death in the other group.Conclusion:Both middle and low doses of dexamethasone can be used as the positive control dose in the experiment of chronic asthmatic rats,but the late side effects of low dose of dexamethasone are less,so the low dose of dexamethasone may be a safer and more suitable dose for the experiment of chronic asthmatic rats. 展开更多
关键词 chronic asthma Rat model DEXAMETHASONE Histological changes
暂未订购
Prevalence of Self-Reported Respiratory Symptoms, Asthma and Chronic Bronchitis in Slum Area of a Rapidly Developing Indian City 被引量:2
2
作者 Bill Brashier Jyoti Londhe +2 位作者 Sapna Madas Vandana Vincent Sundeep Salvi 《Open Journal of Respiratory Diseases》 2012年第3期73-81,共9页
Background: Poverty is an important surrogate marker for obstructive airway diseases (OAD). Slum constitutes a habitat wherein various poverty related parameters are perpetually prevalent in the ambience. 1/6th of wor... Background: Poverty is an important surrogate marker for obstructive airway diseases (OAD). Slum constitutes a habitat wherein various poverty related parameters are perpetually prevalent in the ambience. 1/6th of world population lives in slums yet there is no information regarding their health status in context to asthma and COPD. Aims: We investigated the prevalence of asthma and chronic-bronchitis symptoms and associated risk-factors in slum habitats of Pune city. Methodology: 7062 adult slum-dwellers living in 12 slums of Pune city were cross-sectionally interviewed by local healthcare workers with respiratory health questionnaire which was designed using respiratory symptoms of validated European Community Respiratory Health Survey (ECRHS II) questionnaire and International Union against Tuberculosis and Lung Disease (IUATLD) bronchial symptoms questionnaire. Results: The overall prevalence of selfreported asthma symptoms was 10% (18 - 40 years: 6.5%;>40 years: 13.5%). The overall prevalence of chronic bronchitis was 8.5% [18 - 40 years: 7% (males: 7%, females: 7%);>40 years: 10% (males: 10%, females: 10%)]. Increasing age (p = 0.00), female gender (p = 0.001), unemployment (0.00) current smoking (p = 0.00) and ex-smoking (p = 0.004) emerged as significant risk factor for asthma. While, ex-smoking (p = 0.004) and low-education status (p = 0.00) emerged as significant risk factors for chronic bronchitis. Conclusion: In slums reporting of asthma and chronic-bronchitis symptoms was much higher than what has been reported earlier from India. Asthma was commonly seen in females, old age, unemployed and ever-smokers. While chronic bronchitis was commonly seen in ex-smokers and illiterate subjects. Chronic bronchitis was equally distributed amongst male and females, despite 0% prevalence of smoking in females. 展开更多
关键词 asthma chronic-Bronchitis QUESTIONNAIRE Slum-Population
暂未订购
Asthma-chronic obstructive pulmonary disease overlap syndrome: A diagnostic puzzle for the clinicians
3
作者 Ourania Koltsida Antonia Koutsoukou +1 位作者 Nikolaos G Koulouris Nikoletta Rovina 《World Journal of Respirology》 2016年第2期54-56,共3页
Although asthma and chronic obstructive pulmonary disease(COPD) are distinct airway diseases characterized by chronic inflammation, in some cases distinguishing between them is puzzling. For example, chronic smoking l... Although asthma and chronic obstructive pulmonary disease(COPD) are distinct airway diseases characterized by chronic inflammation, in some cases distinguishing between them is puzzling. For example, chronic smoking leads asthmatic inflammation to a differentiated pattern resembling the COPD inflammation, and in some cases to fixed obstruction as in COPD, and on the other hand, few COPD patients may present with airway reversibility. ACOS is the condition sharing features encountered both in asthma and COPD. Asthma-COPD overlap syndrome(ACOS) represents a diagnostic challenge in the clinical practice, since there is lack of specific indicators to distinguish it from asthma or COPD, and moreover, genetic risk factors, underlying pathology and molecular pathways, clinical characteristics, therapeutic interventions, response to treatment and prognosis are poorly described. The management of ACOS is recommended to be individualized and should target on the maximum effectiveness with the least side effects. Combination therapy with ICS/LABA or LAMA, or newly developed specific anti-eosinophil therapies and treatments specifically targeting neutrophils might be of relevance in the management of ACOS, but studies are needed in order to assess the response and prognosis. Based on the current knowledge about ACOS thus far, it would be recommended that we approached chronic obstructive airway disease rather by describing than by classifying the disease; this would allow us to have a picture that better describes the disease and to implement an individualized therapeutic approach, according to the custom phenotype. Nevertheless, more studies are needed in order to clarify several important issues with regard to ACOS, such as the genetic risk factors for developing ACOS, the links between genotype and phenotype, the molecular pathways and underlying mechanisms of ACOS, the identification of possible specific biomarkers for diagnosis and targeted treatment, the optimal therapeutic interventions, and finally, the prognosis of ACOS. 展开更多
关键词 asthma chronic OBSTRUCTIVE PULMONARY DISEASE asthma-chronic OBSTRUCTIVE PULMONARY DISEASE overlap syndrome DIAGNOSTIC challenges Therapeutic dilemmas
暂未订购
TREATMENT OF CHRONIC BRONCHITIS AND BRONCHIAL ASTHMA WITH MOXIBUSTION IN DOG DAYS
4
作者 王莹 《World Journal of Acupuncture-Moxibustion》 1998年第3期12-15,共4页
Moxibustion in dog days" is a unique therapy for chronic bronchitis and bronchial asthma by means of drug-seperated moxibustion. In the present paper, therapeutic methods, and clinical short-and long-term therape... Moxibustion in dog days" is a unique therapy for chronic bronchitis and bronchial asthma by means of drug-seperated moxibustion. In the present paper, therapeutic methods, and clinical short-and long-term therapeutic effects of "moxibustion in dog days" are introduced and it is indicated that "moxibustion in dog days" has very good the short-and long-term therapeutic effects, with the long-term therapeutic effect better than the short-term one, for chronic bronchitis and bronchial asthma. Also, the concrete methods for increase of the short-term therapeutic effect are put forward. 展开更多
关键词 MOXIBUSTION in DOG DAYS chronic BRONCHITIS BRONCHIAL asthma Observation of clinical therapeutic effects
暂未订购
Easy Breathing—Definition of a Gamification System to Support the Chronic Care of Childhood Asthma
5
作者 Ruofei Hu Jorge Cancela +3 位作者 Giuseppe Fico Cecilia Vera-Muñoz Wenbin Sheng Maria Teresa Arredondo 《Journal of Biomedical Science and Engineering》 2016年第10期122-128,共8页
Asthma is the most common noncommunicable disease among children. It leads to substantial problems both in health and economic terms to individuals and families. This paper introduces a technological solution, Easy Br... Asthma is the most common noncommunicable disease among children. It leads to substantial problems both in health and economic terms to individuals and families. This paper introduces a technological solution, Easy Breathing, that supports the man-agement of childhood asthma, providing tools for both doctors and patients. Through the establishment of an asthma chronic care model, it combines doctors’ professional guidance and a gamification system to improve the compliance of patients with their treatments and to provide them with tools for the self-management of their disease. The system is in the testing phase, the first mockup has been developed and validated with 270 medical experts and patients, and it will be tested with 540 end-users over the next months. 展开更多
关键词 Childhood asthma GAMIFICATION Serious Games chronic Care-Model
暂未订购
咳嗽变异性哮喘误诊原因及鉴别要点分析
6
作者 姜锋 秦良楠 +1 位作者 杨林瀛 米术斌 《临床误诊误治》 2026年第1期7-11,共5页
目的 探讨咳嗽变异性哮喘(CVA)的临床特点、误诊原因及防范措施。方法 回顾性分析2022年6月至2024年6月收治曾误诊的10例CVA病例资料。结果 10例中男6例、女4例,年龄18~45岁。3例以持续性咳嗽伴少量白黏痰为主要表现,查体双肺未闻及明... 目的 探讨咳嗽变异性哮喘(CVA)的临床特点、误诊原因及防范措施。方法 回顾性分析2022年6月至2024年6月收治曾误诊的10例CVA病例资料。结果 10例中男6例、女4例,年龄18~45岁。3例以持续性咳嗽伴少量白黏痰为主要表现,查体双肺未闻及明显啰音,胸部X线检查示肺纹理增粗,初诊为慢性支气管炎,予抗感染及止咳治疗无效,后经支气管激发试验确诊为CVA。3例以反复咳嗽、流涕、鼻塞为主要表现,初诊为上呼吸道感染,予抗病毒及对症治疗无缓解,经肺功能检查及过敏原检测确诊为CVA。4例以刺激性干咳伴咽痒为主要表现,喉镜检查示咽部黏膜充血,初诊为慢性咽炎,治疗后症状反复,最终经支气管激发试验等检查确诊为CVA。本组10例的误诊时间为1~3个月。确诊后予吸入性糖皮质激素联合支气管舒张剂治疗,症状均显著改善。结论 CVA临床表现缺乏特异性,易与慢性支气管炎、上呼吸道感染及慢性咽炎混淆。临床医师应提高对CVA的认识,重视慢性咳嗽的鉴别诊断,及时行肺功能、支气管激发试验等检查,以减少误诊误治。 展开更多
关键词 咳嗽变异性哮喘 误诊 慢性支气管炎 上呼吸道感染 慢性咽炎 肺功能 鉴别诊断
暂未订购
布地奈德福莫特罗联合噻托溴铵在哮喘-慢阻肺重叠综合征治疗中的临床疗效观察
7
作者 胡斯明 《中国现代药物应用》 2026年第3期80-82,共3页
目的探讨布地奈德福莫特罗联合噻托溴铵在哮喘-慢性阻塞性肺疾病(ACOS)重叠综合征治疗中的临床效果。方法选取88例哮喘-慢阻肺重叠综合征患者作为研究对象,采用随机颜色球抽取法分为对照组(采取布地奈德福莫特罗单一治疗,44例)和研究组... 目的探讨布地奈德福莫特罗联合噻托溴铵在哮喘-慢性阻塞性肺疾病(ACOS)重叠综合征治疗中的临床效果。方法选取88例哮喘-慢阻肺重叠综合征患者作为研究对象,采用随机颜色球抽取法分为对照组(采取布地奈德福莫特罗单一治疗,44例)和研究组(采取布地奈德福莫特罗+噻托溴铵联合治疗,44例)。比较两组患者不良反应发生情况、肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、FEV1/FVC]水平。结果研究组不良反应发生率6.82%较对照组的27.27%更低(P<0.05)。治疗后,研究组FVC(2.86±0.54)L、FEV1(2.20±0.56)L、FEV1/FVC(76.92±7.52)%较对照组的(2.52±0.25)L、(1.82±0.41)L、(72.21±7.54)%更高(P<0.05)。结论对于ACOS患者采用布地奈德福莫特罗联合噻托溴铵治疗能更好的改善患者肺功能,减少药物不良反应,ACOS具有推广价值。 展开更多
关键词 布地奈德福莫特罗 噻托溴铵 哮喘-慢性阻塞性肺疾病重叠综合征
暂未订购
糖酵解-乳酸化修饰在哮喘中的潜在作用与治疗展望
8
作者 沈小平 吴东 +1 位作者 于丽丽 吴斌 《中国临床药理学与治疗学》 北大核心 2026年第1期96-106,共11页
哮喘作为一种以气道慢性炎症、气道高反应性及重塑为特征的异质性疾病,其病理机制涉及多种免疫细胞与结构细胞的复杂交互作用。近年研究揭示,糖酵解与哮喘的发病机制、严重程度密切相关,各种免疫细胞中异常的糖酵解代谢可通过诱导先天... 哮喘作为一种以气道慢性炎症、气道高反应性及重塑为特征的异质性疾病,其病理机制涉及多种免疫细胞与结构细胞的复杂交互作用。近年研究揭示,糖酵解与哮喘的发病机制、严重程度密切相关,各种免疫细胞中异常的糖酵解代谢可通过诱导先天性和适应性免疫反应失调来促进哮喘的发病机制。糖酵解终产物的乳酸直接介导了乳酸化修饰,进而调控表观遗传与信号通路,在Th2型炎症、巨噬细胞活化及气道重塑中发挥关键作用,可能成为哮喘病理进程中的潜在的调控节点。本综述讨论了糖酵解-乳酸化在哮喘中的潜在作用和机制,并分析靶向糖酵解-乳酸化通路作为哮喘治疗新策略的可能性,为未来的研究提供参考和方向。 展开更多
关键词 支气管哮喘 慢性气道炎症 糖酵解 乳酸化 代谢重编程
暂未订购
p38 MAPK通路在肺部炎症性疾病中研究进展
9
作者 宋悦 梅梅 +3 位作者 杨松 李慧玲 聂晶 郑永琦 《中西医结合慢性病杂志》 2026年第1期91-96,共6页
p38丝裂原活化蛋白激酶(p38 mitogen-activated protein kinase,p38 MAPK)是丝裂原活化蛋白激酶家族的核心成员,能够在细胞内外环境刺激下可发生磷酸化修饰,并通过激酶级联反应传递信号,进而启动下游应答过程。该通路作为细胞内信号转... p38丝裂原活化蛋白激酶(p38 mitogen-activated protein kinase,p38 MAPK)是丝裂原活化蛋白激酶家族的核心成员,能够在细胞内外环境刺激下可发生磷酸化修饰,并通过激酶级联反应传递信号,进而启动下游应答过程。该通路作为细胞内信号转导的关键枢纽,既能与多条细胞信号通路形成交互式调控网络,又深度参与细胞增殖、分化、凋亡以及机体生长代谢、炎症反应等生理病理过程。大量研究证实,p38 MAPK信号通路与支气管肺发育不良、急性呼吸窘迫综合征、哮喘、慢性阻塞性肺疾病及病毒感染相关性急性肺损伤等肺部炎症性疾病的病理进程密切相关。系统梳理p38 MAPK在上述疾病中的病理生物学调控作用,以期为将该通路作为肺部炎症性疾病新型治疗策略的分子靶点提供理论依据。 展开更多
关键词 p38 MAPK信号通路 支气管肺发育不良 急性呼吸窘迫综合征 哮喘 慢性阻塞性肺疾病
暂未订购
夏鑫华运用“无热便是寒,治肺不远温”思想治疗慢性咳喘经验介绍
10
作者 侯旭阳 戴灿 +1 位作者 林琛 夏鑫华(指导) 《新中医》 2026年第2期163-166,共4页
介绍夏鑫华教授运用“无热便是寒,治肺不远温”思想治疗慢性咳喘的临床经验。夏鑫华教授认为,慢性咳喘的主要致病因素为寒痰。因环境和饮食等多重影响易伤脾胃,致脾阳不足,运化失司,水液代谢失常,上犯于肺,肺失宣降,故现代临床上慢性咳... 介绍夏鑫华教授运用“无热便是寒,治肺不远温”思想治疗慢性咳喘的临床经验。夏鑫华教授认为,慢性咳喘的主要致病因素为寒痰。因环境和饮食等多重影响易伤脾胃,致脾阳不足,运化失司,水液代谢失常,上犯于肺,肺失宣降,故现代临床上慢性咳喘患者多见肺脾不足、痰饮蕴肺证。夏鑫华教授在国医大师洪广祥教授提出的“治肺不远温”的基础上,进一步总结出慢性咳喘病的中医病机及治法,提出“无热便是寒”的学术思想作为慢性咳喘的理论基础,以“无热便是寒,治肺不远温”的思想指导治疗寒证或寒热错杂类型慢性咳喘,以桂枝厚朴杏子汤为基础方,随症化裁,疗效甚佳。 展开更多
关键词 慢性咳喘 阳气虚弱 无热便是寒 治肺不远温 夏鑫华
原文传递
哮喘与慢性阻塞性肺疾病中白细胞介素-13的作用:从致病机制到靶向治疗
11
作者 李子烁 徐霞 《广东医科大学学报》 2026年第1期37-48,共12页
慢性呼吸道疾病(CRDs)是一种以慢性气道炎症和重塑为特征的疾病,主要包括哮喘和慢性阻塞性肺疾病(COPD),其高发病率与死亡率对全球健康构成了严峻的挑战。白细胞介素-13(IL-13)作为2型免疫应答的核心调控因子,一方面可通过IL-4Rα/IL-13... 慢性呼吸道疾病(CRDs)是一种以慢性气道炎症和重塑为特征的疾病,主要包括哮喘和慢性阻塞性肺疾病(COPD),其高发病率与死亡率对全球健康构成了严峻的挑战。白细胞介素-13(IL-13)作为2型免疫应答的核心调控因子,一方面可通过IL-4Rα/IL-13Rα1复合物激活JAK-STAT6经典通路,另一方面也通过IL-13Rα2在肿瘤与纤维化疾病中发挥作用。在哮喘与COPD的发病过程中,IL-13主要通过JAK-STAT6信号通路,驱动黏液高分泌、杯状细胞增生、气道平滑肌异常及上皮屏障破坏等关键病理过程。基于上述机制,本文深入分析了针对IL-13的单克隆抗体、细胞疗法等靶向干预策略的现状与前景,旨在为靶点治疗提供理论依据。 展开更多
关键词 白细胞介素-13 哮喘 慢性阻塞性肺病 发病机制 靶向治疗
暂未订购
颗粒蛋白前体在慢性气道炎症性疾病中的研究进展
12
作者 刘洁婷 谢甜 《国际老年医学杂志》 2026年第1期106-110,共5页
颗粒蛋白前体是一种分泌性糖蛋白,在慢性气道炎症性疾病的发生及发展中扮演着关键角色,有望成为慢性气道炎症性疾病的新型诊断生物标志物和潜在的治疗靶点。本文对颗粒蛋白前体的特性和功能以及在慢性气道炎症性疾病诊疗中的研究进展作... 颗粒蛋白前体是一种分泌性糖蛋白,在慢性气道炎症性疾病的发生及发展中扮演着关键角色,有望成为慢性气道炎症性疾病的新型诊断生物标志物和潜在的治疗靶点。本文对颗粒蛋白前体的特性和功能以及在慢性气道炎症性疾病诊疗中的研究进展作一综述,以期为早期气道炎症性疾病,如慢性阻塞性肺疾病、哮喘等疾病的早期诊断、病情监测及靶向治疗策略提供新的思路,推动颗粒蛋白前体从基础研究向临床应用的转化,为改善患者预后及探索新型诊疗手段奠定理论基础。 展开更多
关键词 颗粒蛋白前体 慢性气道炎症 慢性阻塞性肺疾病 哮喘
暂未订购
舒利迭、倍择瑞吸入治疗哮喘慢阻肺重叠综合征患者的疗效
13
作者 卿红 万丹 《川北医学院学报》 2026年第1期113-117,共5页
目的:探讨舒利迭、倍择瑞吸入治疗哮喘慢阻肺重叠综合征(ACOS)患者的疗效。方法:选取103例ACOS患者为研究对象,根据治疗方案不同分为舒利迭组(n=52)和倍择瑞组(n=51)。舒利迭组患者给予舒利迭治疗;倍择瑞组患者给予倍择瑞治疗,疗程均为9... 目的:探讨舒利迭、倍择瑞吸入治疗哮喘慢阻肺重叠综合征(ACOS)患者的疗效。方法:选取103例ACOS患者为研究对象,根据治疗方案不同分为舒利迭组(n=52)和倍择瑞组(n=51)。舒利迭组患者给予舒利迭治疗;倍择瑞组患者给予倍择瑞治疗,疗程均为90 d。比较两组患者临床疗效、病情控制情况[慢阻肺评分(CAT评分)、哮喘控制评分(ACT评分)]、肺功能改善情况[第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、吸气分数(IC/TLC)]、T淋巴细胞免疫变化[辅助性T细胞17(Th17)、调节性T细胞(Treg)水平]、血清指标水平[白细胞介素17(IL-17)及嗜酸性粒细胞计数(EOS)]、不良反应发生情况及疾病进展情况。结果:倍择瑞组患者临床疗效优于舒利迭组(P<0.05)。治疗后,两组患者CAT评分及FeNO、Th17、EOS、IL-17水平均降低(P<0.05),且倍择瑞组低于舒利迭组(P<0.05);ACT评分及FEV1、FVC、IC/TLC、Treg水平均升高,且倍择瑞组高于舒利迭组(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05);倍择瑞组患者急性加重率、急诊就诊率低于舒利迭组(P<0.05)。结论:倍择瑞可改善ACOS患者肺功能及免疫功能,且安全性好,值得推广应用。 展开更多
关键词 布地格福 沙美特罗替卡松 哮喘慢阻肺重叠综合征 肺功能
暂未订购
射麻口服液联合布地格福吸入气雾剂治疗慢性阻塞性肺疾病急性加重期合并支气管哮喘患者的效果
14
作者 刘素梅 邓颖君 +3 位作者 仇展聪 张凤仪 詹彩梅 钟文英 《中国民康医学》 2026年第2期105-107,111,共4页
目的:观察射麻口服液联合布地格福吸入气雾剂治疗慢性阻塞性肺疾病急性加重期(AECOPD)合并支气管哮喘(BA)患者的效果。方法:选取2024年1—12月该院收治的60例AECOPD合并BA患者进行前瞻性研究,按随机数字表法将其分为研究组和对照组各30... 目的:观察射麻口服液联合布地格福吸入气雾剂治疗慢性阻塞性肺疾病急性加重期(AECOPD)合并支气管哮喘(BA)患者的效果。方法:选取2024年1—12月该院收治的60例AECOPD合并BA患者进行前瞻性研究,按随机数字表法将其分为研究组和对照组各30例。对照组采用布地格福吸入气雾剂治疗,研究组在对照组基础上采用射麻口服液治疗,比较两组治疗前后肺功能指标[第1秒用力呼气容积(FEV_(1))、FEV_(1)/用力肺活量(FVC)]水平、炎性指标[克拉拉细胞蛋白(CC16)、白细胞介素-6(IL-6)]水平、病情程度[慢性阻塞性肺疾病评估测试(CAT)、哮喘控制测试(ACT)]评分,以及不良反应发生率。结果:治疗后,两组FEV_(1)、FEV_(1)/FVC水平均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);治疗后,两组CC16水平均高于治疗前,且研究组高于对照组,两组IL-6水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);治疗后,两组CAT评分均低于治疗前,且研究组低于对照组,两组ACT评分均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:射麻口服液联合布地格福吸入气雾剂治疗AECOPD合并BA患者可提高肺功能指标水平,以及改善炎性指标水平和病情严重程度评分的效果优于单纯布地格福吸入气雾剂治疗。 展开更多
关键词 射麻口服液 布地格福 慢性阻塞性肺疾病急性加重期 支气管哮喘 肺功能 炎性指标
暂未订购
Metabolomic Profiling Differences among Asthma,COPD,and Healthy Subjects:A LC-MS-based Metabolomic Analysis 被引量:4
15
作者 LIANG Ying GAI Xiao Yan +3 位作者 CHANG Chun ZHANG Xu WANG Juan LI Ting Ting 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2019年第9期659-672,共14页
Objective Asthma and chronic obstructive pulmonary disease(COPD)feature different inflammatory and cellular profiles in the airways,indicating that the cellular metabolic pathways regulating these disorders are distin... Objective Asthma and chronic obstructive pulmonary disease(COPD)feature different inflammatory and cellular profiles in the airways,indicating that the cellular metabolic pathways regulating these disorders are distinct.Methods We aimed to compare the serum metabolomic profiles among mild persistent asthmatic patients,individuals with stable COPD,and healthy subjects and to explore the potential metabolic biomarkers and pathways.The serum metabolomic profiles of 17 subjects with mild persistent asthma,17 subjects with stable COPD,and 15 healthy subjects were determined by an untargeted metabolomic an alysis utilizi ng liquid chromatography-mass spectrometry.A series of multivariate statistical an a lyses was subsequently used.Results Multivariate analysis indicated a distinct separation between the asthmatic patients and healthy controls in electrospray positive and negative ions modes,respectively.A total of 19 differential metabolites were identified.Similarly,a distinct separation between asthma and COPD subjects was detected in the two ions modes.A total of 16 differential metabolites were identified.Among the identified metabolites,the serum levels of hypoxanthine were markedly higher in asthmatic subjects compared with those in COPD or healthy subjects.Conclusions Patients with asthma present a unique serum metabolome,which can distinguish them from individuals with COPD and healthy subjects.Purine metabolism alteration may be distinct and involved in the pathogenesis of asthma. 展开更多
关键词 asthma chronic OBSTRUCTIVE pulmonary disease Metabolomics Liquid CHROMATOGRAPHY Mass SPECTROMETRY
暂未订购
家庭药师参与的咳喘药学监护应用效果评价
16
作者 谭燕萍 李玮炜 邵少勤 《中国药业》 2026年第4期143-148,共6页
目的探讨家庭药师参与的咳喘药学监护服务对慢性阻塞性肺疾病(COPD)患者的干预效果。方法选取医院2024年1月至10月收治的COPD患者100例,按随机数字表法分为对照组和观察组,各50例。两组患者均接受常规诊疗模式干预,观察组患者在此基础... 目的探讨家庭药师参与的咳喘药学监护服务对慢性阻塞性肺疾病(COPD)患者的干预效果。方法选取医院2024年1月至10月收治的COPD患者100例,按随机数字表法分为对照组和观察组,各50例。两组患者均接受常规诊疗模式干预,观察组患者在此基础上联合家庭药师参与的咳喘药学监护服务,共干预6个月。比较两组患者干预前后的肺功能、疾病控制情况和呼吸困难程度,满意度、药品不良反应(ADR)发生情况,以及用药依从性。结果干预后,两组患者第1秒用力呼气容积(FEV_(1))占预测值百分比(FEV_(1)%)、FEV_(1)与用力肺活量(FVC)比值均显著升高,疾病控制情况评分、呼吸困难程度评分均显著降低,满意度评分和用药依从性评分均显著升高(P<0.05),且观察组上述指标均显著优于对照组(P<0.05)。观察组ADR发生率显著低于对照组(6.00%比20.00%,P<0.05)。结论家庭药师参与的咳喘药学监护服务可提高COPD患者的肺功能,有利于症状控制,降低呼吸困难程度,同时促进患者满意度和用药依从性的提升,且对ADR有一定预防作用。 展开更多
关键词 家庭药师 慢性阻塞性肺疾病 咳喘 药学监护 肺功能 用药依从性 药品不良反应
暂未订购
Relationship between chronic rhinosinusitis and lower airway diseases: An extensive review 被引量:3
17
作者 Shin Kariya Mitsuhiro Okano Kazunori Nishizaki 《World Journal of Otorhinolaryngology》 2015年第2期44-52,共9页
Signifcant links between allergic rhinitis and asthma have been reported, and the united airway disease hypothesis is supported by numerous findings in epidemiologic, physiologic, pathologic, and immunologic studies. ... Signifcant links between allergic rhinitis and asthma have been reported, and the united airway disease hypothesis is supported by numerous findings in epidemiologic, physiologic, pathologic, and immunologic studies. The impact of allergic rhinitis on asthma has been esta-blished. On the other hand, the relationship between chronic rhinosinusitis and lung diseases has been under investigation. Chronic rhinosinusitis is a common disease, and the high prevalence of chronic rhinosinusitis in some kinds of lung diseases has been reported. Recent studies suggest that the treatment of chronic rhinosinusitis has beneficial effects in the management of asthma. Here, we present an overview of the current research on the relationship between chronic rhinosinusitis and lower airway diseases including asthma, chronic obstructive pul-monary disease, cystic fibrosis, diffuse panbronchiolitis, primary ciliary dyskinesia, idiopathic bronchiectasis, and allergic bronchopulmonary aspergillosis. 展开更多
关键词 chronic rhinosinusitis SINUSITIS asthma chronic obstructive pulmonary disease Cystic fbrosis Diffuse panbronchiolitis Primary ciliary dyskinesia Idiopathic bronchiectasis Allergic bronchopulmonary aspergillosis
暂未订购
Impact of Air Pollutants on Lung Function and Inflammatory Response in Asthma in Shanghai
18
作者 Guifang Wang Youzhi Zhang +6 位作者 Haiyan Yang Yi Yang Liang Dong Peng Zhang Jie Liu Xiaodong Chen Yi Gong 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2024年第8期811-822,共12页
Objective Air pollution is a leading public health issue.This study investigated the effect of air quality and pollutants on pulmonary function and inflammation in patients with asthma in Shanghai.Methods The study mo... Objective Air pollution is a leading public health issue.This study investigated the effect of air quality and pollutants on pulmonary function and inflammation in patients with asthma in Shanghai.Methods The study monitored 27 asthma outpatients for a year,collecting data on weather,patient self-management[daily asthma diary,peak expiratory flow(PEF)monitoring,medication usage],spirometry and serum markers.To explore the potential mechanisms of any effects,asthmatic mice induced by ovalbumin(OVA)were exposed to PM_(2.5).Results Statistical and correlational analyses revealed that air pollutants have both acute and chronic effects on asthma.Acute exposure showed a correlation between PEF and levels of ozone(O_(3))and nitrogen dioxide(NO_(2)).Chronic exposure indicated that interleukin-5(IL-5)and interleukin-13(IL-13)levels correlated with PM_(2.5)and PM_(10)concentrations.In asthmatic mouse models,exposure to PM_(2.5)increased cytokine levels and worsened lung function.Additionally,PM_(2.5)exposure inhibited cell proliferation by blocking the NF-κB and ERK phosphorylation pathways.Conclusion Ambient air pollutants exacerbate asthma by worsening lung function and enhancing Th2-mediated inflammation.Specifically,PM_(2.5)significantly contributes to these adverse effects.Further research is needed to elucidate the mechanisms by which PM_(2.5)impacts asthma. 展开更多
关键词 Ambient air pollutants Acute and chronic effects on asthma PM_(2.5) OVA-induced asthmatic mice
在线阅读 下载PDF
咳喘药学服务门诊工作模式构建与效果分析 被引量:3
19
作者 李翔 李颖 +1 位作者 汪永忠 夏伦祝 《中国药房》 北大核心 2025年第15期1910-1914,共5页
目的建立咳喘药学服务门诊工作模式,分析门诊药学服务干预对患者产生的效果。方法我院开设咳喘药学服务门诊,建立完善的规章制度,配置完整的软硬件设施,并确定药学服务流程。收集2021年5月-2024年12月就诊患者的基本信息,包括性别、年... 目的建立咳喘药学服务门诊工作模式,分析门诊药学服务干预对患者产生的效果。方法我院开设咳喘药学服务门诊,建立完善的规章制度,配置完整的软硬件设施,并确定药学服务流程。收集2021年5月-2024年12月就诊患者的基本信息,包括性别、年龄、居住地和病程等;收集患者就诊和随访时的健康状况、疾病严重程度、吸入剂使用技术和用药依从性等指标,并进行统计分析,以考察药学服务干预对患者的影响。结果确立了我院咳喘药学服务门诊服务流程,共收集了215例患者的基本信息。就诊患者中男性占比为55.35%、平均年龄为(60.91±15.75)岁,60~69岁患者占比最大(28.37%),用药依从性较差[平均得分为(5.64±1.76)分];诊断为慢性阻塞性肺疾病、使用布地奈德福莫特罗粉吸入剂的患者占比最多。68例随访患者中,欧洲五维健康量表评分上升5.81分(P<0.05),慢性阻塞性肺疾病评估测试评分下降4.05分(P<0.05),疾病影响程度减小;哮喘控制测试评分上升4.80分,达到部分控制水平。吸入剂使用技术评分升高2.31分(P<0.05),用药依从性评分升高1.09分(P<0.05),患者满意度超过90%。结论经过药学服务干预后,患者的健康状况、疾病严重程度、吸入剂使用技术和用药依从性均有所改善,对咳喘药学服务门诊满意度较高。咳喘药学服务门诊提供的药学服务干预能改善患者的疾病症状和用药依从性,提高医院合理用药水平。 展开更多
关键词 咳喘 药学门诊 慢性阻塞性肺疾病 哮喘 药学服务
暂未订购
Measurement of Pulmonary Diffusing Capacity for Carbon Monoxide(D_LCO)in Application to Chronic Obstructive Pulmonary Diseases
20
作者 叶曜芩 严文海 +1 位作者 沈曼斐 邓琨 《Journal of Medical Colleges of PLA(China)》 CAS 1990年第2期117-122,共6页
The pulmonary diffusing capacity for carbon monoxide(D_LCO)was measuredin 50 normal subjects,50 patients with emphysema and 31 with asthma.The results sh-owed that the D_LCO value of the asthma group was markedly high... The pulmonary diffusing capacity for carbon monoxide(D_LCO)was measuredin 50 normal subjects,50 patients with emphysema and 31 with asthma.The results sh-owed that the D_LCO value of the asthma group was markedly higher than that of thehealthy group,while the D_LCO/pr% and KCO values of the asthma group were similarto those of the healthy group.The values of D_LCO,D_LCO/pr% and KCO in the emphy-sema group were very significantly lower than those in the asthma and healthy groups.Our study suggests that the measurement of D_LCO is onc of the useful pulmonary func-tion tests in differentiation of emphysema from asthma.The mechanism ofdiffcrcnt D_LCOvalues between emphysema and asthma is discussed.The D_LCO values in patients withmild to severe emphysema gradually decreased with the severity of emphysema.The KCOvalues between the mild emphysema and healthy groups were dramatically different.Thisis helpful in the early diagnosis of emphysma as combined with other clinical data. 展开更多
关键词 asthma chronic OBSTRUCTIVE PULMONARY DISEASES D_LCO
暂未订购
上一页 1 2 79 下一页 到第
使用帮助 返回顶部